Bioqual Inc (OTC:BIOQ)

Monday, September 26, 2022 | Web News
Bioqual Inc. (PINK:BIOQ), a provider of research, development, consulting and testing/assay services to commercial clients and Government laboratories announced Q4 2022 results:...
Monday, September 20, 2021 | Web News
Bioqual Inc. (PINK:BIOQ) ($84.50, $64.3M market cap), a provider of research, development, consulting and...
Friday, September 20, 2019 | Web News
September 20, 2019 Dear Shareholder, BIOQUAL completed fiscal year 2019 (June 1, 2018 to May 31, 2019} with an increase in revenues...
See All Research...

Bioqual, Inc., through its subsidiary, Enhanced Therapeutics, Inc., provides research, development, and consulting services to government and commercial contract clients. It offers research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, antibody production, preclinical vaccine, transgenics, contraception, breeding and development of genetically defined animals, and neurobiology and behavior. The company also conducts studies on reproductive endocrinology and toxicology, infectious diseases, and environmental enrichment and behavior, as well as offers laboratory services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Web site: http://www.bioqual.com

Last updated March 5, 2008


Market Data powered by QuoteMedia. Terms of Use